C61 C64 C67
Conditions
Interventions
Group 1: Healthy individuals (sample collection, evaluation of tumor markers in urine, blood, tissue)
Group 2: Patients with prostate cancer (sample collection, evaluation of tumor markers in urine, b
Sponsors
Universtitätsklinikum FreiburgDepartment ChirurgieKlinik für Urologie
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patient with urological tumor or individual without tumor as control group
Exclusion criteria
Exclusion criteria: refusal of participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of potential biomarkers for tumors | — |
Secondary
| Measure | Time frame |
|---|---|
| Validation and Evaluation of sensitivity and specificity of potential biomarkers | — |
Countries
Germany
Contacts
Public ContactKonrad Wilhelm
Universtitätsklinikum FreiburgDepartment ChirurgieKlinik für Urologie
Outcome results
None listed